The Role of the SRY Gene in Sex Determination

SRY, short for Sex-determining Region Y, is a gene on the Y chromosome that acts as the master switch for male sex determination in mammals. When it was identified in 1990, researchers confirmed it had the properties expected of the long-sought “testis-determining factor,” the gene responsible for diverting an otherwise female-default developmental pathway toward male anatomy.¹ But SRY does not work alone, and its story is stranger and more fragile than a simple on/off switch would suggest.

How the SRY Protein Works

The SRY gene encodes a protein whose critical feature is a roughly 70-amino-acid DNA-binding domain called the HMG box. This domain latches onto specific stretches of DNA and bends them sharply, physically reshaping the double helix in a way that allows other genes to be activated.² The bending is not incidental. The tail end of the HMG box acts as a kind of molecular clamp that locks the bent shape in place, and experiments show this stabilization is essential for the protein to do its job.³

The most important downstream effect of SRY’s DNA bending is the activation of another gene called SOX9. Once SRY flips on SOX9 in the cells of the developing gonad, SOX9 drives those cells to become Sertoli cells, the key structural cells of the testis. In mouse studies, SOX9 expression rises immediately after SRY expression in normal development.⁴ If that handoff from SRY to SOX9 is too slow or too weak, the window for male development closes and ovarian pathways take over instead, even in an embryo carrying a Y chromosome.

The Narrow Window of Expression

SRY does not stay on permanently. In mice, its expression is restricted to gonadal cells during a tight developmental window, roughly 10.5 to 12.5 days after conception. What controls this timing? A major part of the answer is DNA methylation, an epigenetic mechanism that silences genes by attaching chemical tags to their regulatory regions. Before SRY needs to turn on, its promoter region is heavily methylated, keeping it quiet. At the moment of gonadal development, that methylation is specifically stripped away in the cells of the gonad, while other tissues keep SRY locked down.⁵

More recent work has identified one of the molecular tools responsible for this demethylation. An enzyme called TET2 converts methylation marks on the SRY promoter into a modified form that the cell recognizes as a signal for removal. The levels of this modified form track closely with SRY expression during gonad development, rising and falling in step with it.⁶ This means that whether SRY turns on at the right time depends on the epigenetic machinery of the cell, not just on whether the gene itself is present. A perfectly intact SRY gene could theoretically fail to produce male development if the demethylation process went wrong.

A Tug of War, Not a Simple Switch

The traditional textbook picture presents sex determination as binary: SRY present equals male, SRY absent equals female. The reality is more like an active contest. SRY and its downstream target SOX9 work alongside a signaling molecule called FGF9 to push the gonad toward testis formation. But at the same time, a competing set of signals, including WNT4 and possibly RSPO1, push the same tissue toward ovarian development.⁷

These two pathways are not sequential. They are running simultaneously in the early gonad, and the outcome depends on which set of signals gains the upper hand. In normal XY development, SRY tips the balance toward the male side quickly enough that the male-promoting signals snowball and suppress the female pathway. In normal XX development, without SRY to give the male side its head start, the female-promoting signals dominate. But because both pathways are always present, relatively small disruptions can tip the balance in surprising directions.

When SRY Mutations Cause Female Development in XY Individuals

The clearest clinical proof that SRY is the decisive factor in male sex determination comes from Swyer syndrome, a condition in which individuals carry a 46,XY karyotype but develop as phenotypic females. People with Swyer syndrome have female external anatomy, a uterus that is typically normal or slightly underdeveloped, and streak gonads, meaning their gonads never developed into functional testes or ovaries.⁸ They often come to medical attention only during adolescence, when puberty fails to occur.

The underlying cause is a loss-of-function change in SRY. This can be a point mutation within the HMG box that cripples the protein’s ability to bind or bend DNA.⁹ It can also be a microdeletion that removes part of the gene entirely.⁸ In either case, the result is the same: without a working SRY protein, the embryonic gonad never receives the signal to become a testis, and the female-promoting pathways take over by default.¹⁰ Because the streak gonads do not produce hormones, individuals with Swyer syndrome need hormone replacement therapy to undergo puberty and maintain bone health. The streak gonads themselves carry a risk of developing tumors and are usually removed surgically.

When SRY Shows Up on the Wrong Chromosome

The mirror image of Swyer syndrome is 46,XX male syndrome, sometimes called de la Chapelle syndrome. Here, an individual has two X chromosomes and no Y chromosome, yet develops male anatomy. The most common explanation is that during the father’s sperm production, a small piece of the Y chromosome carrying SRY gets accidentally stuck onto an X chromosome.¹¹ The resulting offspring inherits this modified X chromosome, and the SRY gene it carries is enough to trigger testis development.¹²

People with XX male syndrome typically have a male appearance and male gender identity, but they tend to be shorter than average and are almost always infertile. Because they lack the rest of the Y chromosome, they are missing genes needed for sperm production. They may also have lower testosterone levels and sometimes develop breast tissue. This condition demonstrates something important about SRY’s role: it is sufficient to initiate testis formation even without the rest of the Y chromosome, but the Y chromosome carries other genes needed for complete male reproductive function.

Sex Reversal Can Happen Without Touching SRY

If the downstream genes that SRY activates are themselves disrupted, sex reversal can occur even when SRY is perfectly normal. The most dramatic demonstration comes from a study of a single regulatory element controlling SOX9 expression. Researchers identified a short stretch of DNA, called Enh13, embedded within a region whose deletion in humans is associated with XY sex reversal. This enhancer is conserved across species, and when it was knocked out in mice, XY animals developed as females despite having an intact SRY gene.¹³

This finding underscores a point that genetic counselors and researchers encounter regularly: not every case of differences in sex development traces back to an SRY mutation. Some cases involve mutations in SOX9 itself, in its regulatory elements, or in the competing female-promoting pathway genes. Sex determination is a cascade, and SRY is the trigger at the top. But a broken link anywhere further down the chain can derail the process just as effectively.

Where SRY Came From

SRY is a relatively recent evolutionary invention. Gene mapping and sequence comparisons across mammals show that SRY arose as a degraded copy of SOX3, a gene located on the X chromosome.¹⁴ SOX3 is involved in brain development and has nothing to do with sex determination on its own. At some point in the evolutionary history of mammals, SOX3 was copied onto the proto-Y chromosome, lost most of its original sequence, and through accumulated mutations gained the ability to trigger testis formation.¹⁵

One of the more puzzling features of SRY is how fast it evolves. For a gene that performs such a critical function, you would expect it to be tightly conserved across species. The HMG box domain is indeed fairly stable, but the flanking regions of the protein diverge wildly between mammalian lineages. In primates, the rate of sequence-changing mutations in these flanking regions actually exceeds the rate of silent mutations, which is unusual and suggests either that most of the protein outside the HMG box is functionally irrelevant, or that it is being shaped by some form of positive selection.¹⁶ Analysis across primates, rodents, and cattle confirms the same pattern: the HMG box stays recognizable, while the rest of the gene scrambles rapidly.¹⁷

Mammals That Determine Sex Without SRY

If SRY is the master switch for mammalian sex determination, how do you explain mammals that have lost it entirely? At least two groups of rodents manage sex determination without any detectable SRY gene. Two subspecies of the Amami spiny rat, a small rodent native to Japanese islands, lack SRY altogether, as confirmed by DNA probing.¹⁸ The Mandarin vole similarly shows no evidence of a functional SRY gene, even though males and females otherwise look and behave as expected for their sex.¹⁹

How these species determine sex remains an open question. Some researchers suspect that a different gene has been recruited to fill SRY’s role, while others think a dosage-based mechanism involving existing genes on the X chromosome may have taken over. Whatever the answer, these species prove that SRY is not the only way for a mammal to solve the problem of sex determination. It is the solution that most mammals settled on, but evolution has found workarounds when SRY was lost.

DMRT1 and the Broader Landscape of Sex-Determining Genes

Zooming out beyond mammals makes SRY look even more like a newcomer. In birds, sex determination runs on a completely different system: males carry two Z chromosomes, and females carry one Z and one W. The gene at the center of this system is DMRT1, and it works by dosage. Two copies in ZZ individuals drive testis formation; one copy in ZW individuals is not enough, so ovaries develop instead.²⁰ DMRT1 also plays critical roles in fish and reptile sex determination.

What makes this interesting for understanding SRY is that DMRT1 has not disappeared in mammals; it has just been demoted. In mice, deleting DMRT1 does not prevent fetal testis formation at all. It only causes problems after birth, affecting sperm production. But recent work in rabbits has shown that DMRT1 is still required for testis determination in that species, and that losing even one copy leads to secondary infertility.²¹ This suggests an evolutionary continuum in which DMRT1 was the ancestral sex-determination gene, SRY later stepped in as a trigger at the top of the cascade, and the degree to which DMRT1 remains essential varies from species to species. Mice may be unusual in how thoroughly SRY has replaced DMRT1’s fetal role, while rabbits and possibly other non-rodent mammals still depend on both.

SRY Expression in the Brain

SRY’s job description may extend beyond the gonads. Researchers have found that the gene is expressed in the adult male rodent brain, specifically in dopamine-producing neurons in the substantia nigra, a brain region involved in movement control. When they experimentally dialed down SRY expression in that region, the affected rats showed a measurable decrease in the enzyme that produces dopamine and developed motor problems as a result.²² This effect occurred without any change in the total number of neurons and without involvement of gonadal hormones, suggesting SRY was directly influencing brain chemistry.

Whether SRY plays a similar role in the human brain is less clear. The gene is expressed in certain regions of the human brain, and researchers have speculated about potential connections to sex differences in neurological conditions like Parkinson’s disease, which affects men at higher rates.²³ But the leap from rodent experiments to human disease causation is enormous, and the work remains largely exploratory. Still, the finding that a “sex determination” gene has a second career in the adult brain is a reminder that genes are often less single-purpose than their names suggest.

SRY Testing in Athletics

The identification of SRY opened a door that sports governing bodies walked through with mixed results. At the 1992 Barcelona Olympics, sex verification of female athletes was performed using a molecular test that looked for Y chromosome sequences, including SRY, in cheek-swab samples from over 2,400 female competitors.²⁴ A positive result triggered further investigation, including a test for SRY specifically.

The problem, as the clinical conditions described earlier make plain, is that the presence or absence of SRY does not map cleanly onto athletic advantage. A woman with complete androgen insensitivity syndrome might carry a Y chromosome and a functional SRY gene but develop entirely female anatomy because her cells cannot respond to testosterone. Testing her as “male” on the basis of SRY would be biologically meaningless. Conversely, a woman with XX male syndrome might be SRY-positive but raised female and competing without any hormonal advantage. These cases made SRY-based sex testing deeply controversial, and major sporting bodies have since moved away from blanket genetic testing, though the broader issue of eligibility criteria for athletes with differences in sex development remains contentious.

Engineering Sex Ratios in Livestock

On the applied side, understanding SRY’s chromosomal location has helped researchers develop tools for skewing sex ratios in animals. In agriculture, the sex of offspring matters economically: dairy operations want more females, while beef cattle operations may prefer males. A recent study in mice demonstrated a genetic approach in which a construct inserted on the Y or X chromosome disrupts the transmission of the opposite sex chromosome during sperm formation. When placed on the Y chromosome, one version produced litters that were about 88% female, a dramatic shift from the normal fifty-fifty split.²⁵ A complementary version on the X chromosome generated roughly 78% male offspring. These tools exploit the same chromosomal real estate where SRY sits, though they work by a different mechanism entirely, selectively crippling sperm that carry the unwanted sex chromosome rather than manipulating SRY itself. The technology is still in the lab-mouse stage, but it illustrates how deeply the molecular understanding of sex chromosomes has advanced since SRY’s discovery three decades ago.